Charles Schwab Investment Management Inc Dynavax Technologies Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,155,080 shares of DVAX stock, worth $15.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,155,080
Previous 1,122,733
2.88%
Holding current value
$15.9 Million
Previous $12.5 Million
17.93%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$302 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$245 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$126 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$107 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$90.5 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.74B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...